CA
MRNA icon

Cornerstone Advisors’s Moderna MRNA Stock Holding History

Cornerstone Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,800
Closed -$49.7K – 267
2025
Q2 		$49.7K Hold
1,800
– – ﹤0.01% 271
2025
Q1 		$51K Hold
1,800
– – ﹤0.01% 264
2024
Q4 		$74.8K Hold
1,800
– – ﹤0.01% 265
2024
Q3 		$120K Buy
1,800
+800
+80% +$73.4K ﹤0.01% 275
2024
Q2 		$119K Sell
1,000
-8,200
-89% -$1.04M ﹤0.01% 293
2024
Q1 		$980K Hold
9,200
– – 0.04% 272
2023
Q4 		$915K Sell
9,200
-1,400
-13% -$118K 0.04% 261
2023
Q3 		$1.09M Buy
+10,600
New +$1.18M 0.05% 247
2022
Q2 		– Sell
-5,000
Closed -$861K – 196
2022
Q1 		$861K Hold
5,000
– – 0.05% 154
2021
Q4 		$1.27M Buy
+5,000
New +$1.46M 0.07% 161

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cornerstone Advisors's MRNA Position: Q3 2025 in Review

Cornerstone Advisors sold out of Moderna (MRNA) in Q3 2025, closing a stake of 1,800 shares — an estimated $49.7K sold.

Cornerstone Advisors first reported a position in MRNA in Q4 2021 and held it in 10 quarters. The position peaked at $1.27M in Q4 2021. 646 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Cornerstone Advisors reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Cornerstone Advisors sold 1,800 Moderna shares in Q3 2025, an estimated $49.7K.
  • Cornerstone Advisors first reported a position in Moderna in Q4 2021 and held it in 10 quarters.
  • Cornerstone Advisors's Moderna position peaked at $1.27M in Q4 2021.
  • 646 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Cornerstone Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.